Burrage Capital Management as of Sept. 30, 2020
Portfolio Holdings for Burrage Capital Management
Burrage Capital Management holds 27 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Epizyme | 9.4 | $12M | 1.0M | 11.93 | |
| Aimmune Therapeutics | 9.0 | $12M | 333k | 34.45 | |
| Mei Pharma | 7.5 | $9.5M | 3.0M | 3.12 | |
| Iveric Bio | 6.7 | $8.4M | 1.5M | 5.64 | |
| Ptc Therapeutics I (PTCT) | 6.4 | $8.1M | 174k | 46.75 | |
| Orthopediatrics Corp. (KIDS) | 6.2 | $7.9M | 172k | 45.92 | |
| NeoGenomics (NEO) | 5.6 | $7.1M | 193k | 36.89 | |
| Turning Point Therapeutics I | 5.4 | $6.8M | 78k | 87.36 | |
| Cytokinetics (CYTK) | 4.5 | $5.7M | 265k | 21.65 | |
| Aurinia Pharmaceuticals (AUPH) | 4.2 | $5.3M | 362k | 14.73 | |
| Insmed (INSM) | 4.2 | $5.3M | 165k | 32.14 | |
| Anaptysbio Inc Common (ANAB) | 3.8 | $4.9M | 331k | 14.75 | |
| Y Mabs Therapeutics (YMAB) | 3.7 | $4.7M | 123k | 38.39 | |
| Adc Therapeutics Sa SHS (ADCT) | 3.5 | $4.5M | 135k | 32.99 | |
| Crinetics Pharmaceuticals In (CRNX) | 3.0 | $3.8M | 241k | 15.67 | |
| Assembly Biosciences | 2.6 | $3.3M | 200k | 16.44 | |
| Regenxbio Inc equity us cm (RGNX) | 2.5 | $3.2M | 116k | 27.52 | |
| G1 Therapeutics (GTHX) | 2.1 | $2.6M | 229k | 11.55 | |
| Frequency Therapeutics | 2.0 | $2.6M | 134k | 19.21 | |
| Apellis Pharmaceuticals (APLS) | 1.8 | $2.3M | 77k | 30.17 | |
| Fulcrum Therapeutics (FULC) | 1.8 | $2.3M | 292k | 7.93 | |
| Tricida | 1.3 | $1.7M | 188k | 9.06 | |
| Merus N V (MRUS) | 1.3 | $1.7M | 140k | 12.00 | |
| Zogenix | 0.6 | $703k | 39k | 17.94 | |
| Aduro Biotech | 0.3 | $330k | 136k | 2.43 | |
| Calliditas Therapeutics Ab Sponsered Ads (CALT) | 0.2 | $265k | 11k | 24.02 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $175k | 15k | 11.66 |
